article thumbnail

W2O acquires health policy consulting firm Discern Health

pharmaphorum

The move will give Discern Health access to healthcare communications agency W2O ’s proprietary data models and tools, as well as its 1,400-person-strong multidisciplinary team – including data analysts, scientific strategists, branding experts, communications specialists and creatives. We will truly be #BetterTogether.”.

article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS Pharmaceutical Strategy for Europe. THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION; 2004. Maarten has significant competition law experience in a variety of sectors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthware Group announces acquisition of Argon Global Healthcare Network

pharmaphorum

Established in 2004, Argon Global Healthcare long term growth strategy has been based on identifying outstanding independently owned healthcare communication agencies with proven track record and integrating them in a solid structure covering the major markets in EMEA, Americas and APAC.

article thumbnail

Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

pharmaphorum

healthcare facilities were found to have an EHR system fully implemented by 2004. Their patient journey typically requires engaging with discrete service providers, who are often using antiquated means of communication. Many are still making the transition. Today, specialty drug sales represent more than half of all drug spending.

HIPAA 98
article thumbnail

Pharma responds to proposed EU pharmaceutical legislation reform

European Pharmaceutical Review

Pinsent Masons Charlotte Weekes, Senior Associate at Pinsent Masons shared with EPR : “The Commission’s ambitious pharma legislation review is the first significant review of the European system since 2004.” “It

article thumbnail

A Life in a Day by The Method

pharmaphorum

The Method is a British-based company founded by Doyle and his business partner, John Keates, in 2004. “By living the life of a patient in one day, it unlocks a deeper understanding of patients’ needs that can be used to build more meaningful patient-centric strategies across all business units.”.

article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”. Throughout 2022, Novartis was at the opposing ends of legal cases.